Early prediction of improvement in ejection fraction after acute myocardial infarction using low dose dobutamine echocardiography

Heart

Volumn 88, Issue 6, 2002, Pages 592-596

  Nijland, Francisca ^a   Kamp, O ^a   Verhorst, P M J ^a   De Voogt, W G ^b   Visser, C A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; Q WAVE; RECEIVER OPERATING CHARACTERISTIC; STRESS ECHOCARDIOGRAPHY;

EID: 0036899733     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.6.592     Document Type: Article

References (32)

1. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
2. Volpi A, De Vita C, Franzosi MG, et al and the ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 data base. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. Circulation 1993;88:416-29.
3. Stadius ML, Davis K, Maynard C, et al. Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial. Circulation 1986;74:703-11.
4. Sheehan FH, Braunwald E, Canner P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue-type plasminogen activator and streptokinase from the thrombolysis in myocardial infarction (TIMI phase I) trial. Circulation 1987;75:817-29.
5. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 1989;320:618-27.
6. O'Neill W, Timmis GC, Bourdillon PD, et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med 1986;314:812-18.
7. Serruys PW, Simoons ML, Suryapranata H, et al. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol 1986;7:729-42.
8. Schmidt WG, Sheehan FH, von Essen R, et al. Evolution of left ventricular function after intracoronary thrombolysis for acute myocardial infarction. Am J Cardiol 1989;63:497-502.
9. Harrison JK, Califf RM, Woodlief LH, et al and the TAMI Study Group. Systolic left ventricular function after reperfusion therapy for acute myocardial infarction. An analysis of determinants of improvement. Circulation 1993;87:1531-41.
10. Henzlova MJ, Bourge RC, Papapietro SE, et al. Long-term effect of thrombolytic therapy on left ventricular ejection fraction after acute myocardial infarction. Am J Cardiol 1991;67:1354-9.
11. Marzoll U, Kleiman NS, Dunn JK, et al. Factors determining improvement in left ventricular function after reperfusion therapy for acute myocardial infarction: Primacy of baseline ejection fraction. J Am Coll Cardiol 1991;17:613-20.
12. Brodie BR, Weintraub RA, Hansen CJ, et al. Factors that predict improvement in left ventricular ejection fraction after coronary angioplasty for acute myocardial infarction. Cathet Cardiovasc Diagn 1987;13:372-80.
13. Lee H, Eisenberg MJ, Schiller NB. Serial assessment of left ventricular function after myocardial infarction. Am Heart J 1995;130:999-1002.
14. Humbert VH, Jabi H, Burger AJ, et al. Late variation in ventricular function after myocardial infarction. Chest 1991;100:28-33.
15. Sheehan FH, Doerr R, Schmidt WG, et al. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: An important determinant of survival. J Am Coll Cardiol 1988;12:289-300.
16. Brodie BR, Stuckey TD, Kissling G, et al. Importance of infarct-related artery patency for recovery of left ventricular function and late survival after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1996;28:319-25.
17. Pierard LA, DeLandsheere CM, Berthe C, et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-31.
18. Barilla F, Gheorghiade M, Alam M, et al. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122:1522-31.
19. Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15.
20. Previtali M, Poli A, Lanzarini L, et al. Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol 1993;72:124-30G.
21. Salustri A, Elhendy A, Garyfallydis P, et al. Prediction of recovery of ventricular dysfunction after first acute myocardial infarction using low-dose dobutamine echocardiography. Am J Cardiol 1994;74:853-66.
22. Watada H, Ito H, Oh H, et al. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 1994;24:624-30.
23. Kan G, Visser CA, Koolen JJ, et al. Short and long term predictive value of admission wall motion score in acute myocardial infarction: A cross sectional echocardiographic study of 345 patients. Br Heart J 1986;56:422-7.
24. Schiller N, Shah PM, Crawford M, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Subcommittee on Standards. J Am Soc Echocardiogr 1989;2:358-68.
25. Miketic S, Carsson J, Tebbe U. Improvement of global and regional left ventricular function by percutaneous transluminal coronary angioplasty after myocardial infarction. J Am Coll Cardiol 1995;25:843-7.
26. Kereiakes DJ, Califf RM, George BS, et al, and the TAMI Group. Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction. Am Heart J 1991;112:390-9.
27. Meijer A, Verheugt FWA, v Eenige MJ, et al. Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without infarction on ejection fraction, regional function and remodeling. Circulation 1994;90:1706-14.
28. Cintron G, Johnson G Francis G, et al, for the V-HeFT VA Cooperative Studies Group. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation 1993;87(suppl VI):VI-17-23.
29. Cornel JH, Bax JJ, Elhendy A, et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease. Implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 1998;31:1002-10.
30. Vanoverschelde JLJ, D'Hondt AM, Marwick T, et al. Head to head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low-dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996;28:432-42.
31. Meluzin J, Cigarroa CG, Brickner E, et al. Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarcts. Am J Cardiol 1995;76:877-80.
32. Bax JJ, Cornel JH, Visser FC, et al. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of FDG/thallium SPECT, thallium stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996;28:558-64.